Last 12 months
Inside the activity.
3 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 2 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 07, 2018 Filed Nov 7, 2018 18:18 UTC |
Orticerio ErnestSVP Finance and Corporate Dev
|
SaleCommon Stock | 8,829 | $16.53 | $145,908.94 |
DisclosureSEC source: 0001562180-18-004456 · primarydocument.xml · nonDerivative · entry 6 Orticerio Ernest · CIK 0001724369 · SVP Finance and Corporate Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,802 F3 · price: This transaction was executed in multiple trades at prices ranging from $16.50 to $16.69. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 7,131 restricted stock units that vest as to 25% of the shares on May 10, 2019 and as to an additional 2.083% of the shares per month for 36 months thereafter. Read SEC document |
| November 07, 2018 Filed Nov 7, 2018 18:18 UTC |
Orticerio ErnestSVP Finance and Corporate Dev
|
Exercise / conversionCommon Stock | 8,829 | $2.28 | $20,130.12 |
DisclosureSEC source: 0001562180-18-004456 · primarydocument.xml · nonDerivative · entry 5 Orticerio Ernest · CIK 0001724369 · SVP Finance and Corporate Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,631 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 7,131 restricted stock units that vest as to 25% of the shares on May 10, 2019 and as to an additional 2.083% of the shares per month for 36 months thereafter. Read SEC document |
| November 07, 2018 Filed Nov 7, 2018 18:18 UTC |
Orticerio ErnestSVP Finance and Corporate Dev
|
SaleCommon Stock | 1,171 | $16.50 | $19,321.50 |
DisclosureSEC source: 0001562180-18-004456 · primarydocument.xml · nonDerivative · entry 4 Orticerio Ernest · CIK 0001724369 · SVP Finance and Corporate Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,802 F1 · balance_after: Includes 7,131 restricted stock units that vest as to 25% of the shares on May 10, 2019 and as to an additional 2.083% of the shares per month for 36 months thereafter. Read SEC document |
| November 07, 2018 Filed Nov 7, 2018 18:18 UTC |
Orticerio ErnestSVP Finance and Corporate Dev
|
Exercise / conversionCommon Stock | 1,171 | $2.28 | $2,669.88 |
DisclosureSEC source: 0001562180-18-004456 · primarydocument.xml · nonDerivative · entry 3 Orticerio Ernest · CIK 0001724369 · SVP Finance and Corporate Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,973 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 7,131 restricted stock units that vest as to 25% of the shares on May 10, 2019 and as to an additional 2.083% of the shares per month for 36 months thereafter. Read SEC document |
| November 05, 2018 Filed Nov 7, 2018 18:18 UTC |
Orticerio ErnestSVP Finance and Corporate Dev
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $2.28 | $0.00 |
DisclosureSEC source: 0001562180-18-004456 · primarydocument.xml · derivative · entry 7 Orticerio Ernest · CIK 0001724369 · SVP Finance and Corporate Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,670 Underlying: Common Stock · 10,000 shares Expires 2022-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: All shares underlying the option have vested. Read SEC document |
| November 05, 2018 Filed Nov 7, 2018 18:18 UTC |
Orticerio ErnestSVP Finance and Corporate Dev
|
SaleCommon Stock | 10,000 | $17.12 | $171,240.00 |
DisclosureSEC source: 0001562180-18-004456 · primarydocument.xml · nonDerivative · entry 2 Orticerio Ernest · CIK 0001724369 · SVP Finance and Corporate Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,802 F2 · price: This transaction was executed in multiple trades at prices ranging from $17.10 to $17.21. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 7,131 restricted stock units that vest as to 25% of the shares on May 10, 2019 and as to an additional 2.083% of the shares per month for 36 months thereafter. Read SEC document |
| November 05, 2018 Filed Nov 7, 2018 18:18 UTC |
Orticerio ErnestSVP Finance and Corporate Dev
|
Exercise / conversionCommon Stock | 10,000 | $2.28 | $22,800.00 |
DisclosureSEC source: 0001562180-18-004456 · primarydocument.xml · nonDerivative · entry 1 Orticerio Ernest · CIK 0001724369 · SVP Finance and Corporate Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,802 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 7,131 restricted stock units that vest as to 25% of the shares on May 10, 2019 and as to an additional 2.083% of the shares per month for 36 months thereafter. Read SEC document |
| November 01, 2018 Filed Nov 5, 2018 17:30 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 2,829 | $17.97 | $50,842.79 |
DisclosureSEC source: 0001562180-18-004421 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,170,239 F1 · shares: The sale of shares reported on this Form 4 was made solely to cover tax obligations upon the vesting of 6,250 RSUs and was effected pursuant to a Rule 10b5-1 trading plan adopted on August 14, 2018. F2 · price: This transaction was executed in multiple trades at prices ranging from $17.82 to $18.0148. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 39,815 shares of common stock that are subject to performance based vesting and 237,500 restricted stock units. Read SEC document |
| October 31, 2018 Filed Oct 31, 2018 23:44 UTC |
Duffy David C.SVP R&D and CTO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,354 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001562180-18-004345 · primarydocument.xml · derivative · entry 4 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,202 Underlying: Common Stock · 1,354 shares Expires 2021-07-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% @ 1 year, monthly on last day of month thereafter for 3 years (starting in 12th month) beginning on 06-Jul-2011 Read SEC document |
| October 31, 2018 Filed Oct 31, 2018 23:44 UTC |
Duffy David C.SVP R&D and CTO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,860 | $0.00 Strike: $2.28 | $0.00 |
DisclosureSEC source: 0001562180-18-004345 · primarydocument.xml · derivative · entry 3 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,253 Underlying: Common Stock · 1,860 shares Expires 2022-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 25% @ 1 year, monthly on last day of month thereafter for 3 years (starting in 12th month) beginning on 01-Nov-2011 Read SEC document |
| October 31, 2018 Filed Oct 31, 2018 23:44 UTC |
Duffy David C.SVP R&D and CTO
|
Exercise / conversionCommon Stock | 1,860 | $2.28 | $4,240.80 |
DisclosureSEC source: 0001562180-18-004345 · primarydocument.xml · nonDerivative · entry 2 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,812 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 5,485 restricted stock units that vest as to 25% of the shares on May 10, 2019 and as to an additional 2.083% of the shares per month for 36 months thereafter. Read SEC document |
| October 31, 2018 Filed Oct 31, 2018 23:44 UTC |
Duffy David C.SVP R&D and CTO
|
Exercise / conversionCommon Stock | 1,354 | $1.93 | $2,613.22 |
DisclosureSEC source: 0001562180-18-004345 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,952 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 5,485 restricted stock units that vest as to 25% of the shares on May 10, 2019 and as to an additional 2.083% of the shares per month for 36 months thereafter. Read SEC document |
| October 02, 2018 Filed Oct 3, 2018 16:01 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 2,995 | $20.91 | $62,610.48 |
DisclosureSEC source: 0001562180-18-004143 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,173,068 F1 · shares: The sale of shares reported on this Form 4 was made solely to cover tax obligations upon the vesting of 6,250 RSUs and was effected pursuant to a Rule 10b5-1 trading plan adopted on August 14, 2018. F2 · price: This transaction was executed in multiple trades at prices ranging from $20.63 to $21.23. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 39,815 shares of common stock that are subject to performance based vesting and 243,750 restricted stock units. Read SEC document |
| September 05, 2018 Filed Sep 7, 2018 16:22 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 17,909 | $14.53 | $260,242.84 |
DisclosureSEC source: 0001562180-18-003866 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,176,063 F1 · shares: The sale of shares reported on this Form 4 was made solely to cover tax obligations upon the vesting of 50,000 RSUs and was effected pursuant to a Rule 10b5-1 trading plan adopted on August 14, 2018. F2 · price: This transaction was executed in multiple trades at prices ranging from $14.10 to $15.10. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 39,815 shares of common stock that are subject to performance based vesting and 250,000 restricted stock units. Read SEC document |
| August 07, 2018 Filed Aug 10, 2018 00:12 UTC |
MEISTER PAUL MDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,900 | $0.00 Strike: $14.80 | $0.00 |
DisclosureSEC source: 0001104659-18-051031 · a4.xml · derivative · entry 2 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,900 Underlying: Common Stock · 7,900 shares Expires 2028-08-07 Read SEC document |
| August 07, 2018 Filed Aug 10, 2018 00:12 UTC |
MEISTER PAUL MDirector
|
GrantCommon Stock | 2,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-051031 · a4.xml · nonDerivative · entry 1 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,270 F1 · shares: Represents restricted stock units that vest as to 100% of the shares on December 31, 2018. Each restricted stock unit represents the right to receive one share of the Issuer's common stock. F2 · balance_after: Represents 2,270 restricted stock units. Read SEC document |
| August 07, 2018 Filed Aug 10, 2018 00:12 UTC |
Cole Douglas G.Director
|
GrantStock Option (Right to Buy) · Derivative | 7,900 | $0.00 Strike: $14.80 | $0.00 |
DisclosureSEC source: 0001104659-18-051029 · a4.xml · derivative · entry 2 Cole Douglas G. · CIK 0001486373 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,900 Underlying: Common Stock · 7,900 shares Expires 2028-08-07 Read SEC document |
| August 07, 2018 Filed Aug 10, 2018 00:12 UTC |
Cole Douglas G.Director
|
GrantCommon Stock | 2,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-051029 · a4.xml · nonDerivative · entry 1 Cole Douglas G. · CIK 0001486373 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,270 F1 · shares: Represents restricted stock units that vest as to 100% of the shares on December 31, 2018. Each restricted stock unit represents the right to receive one share of the Issuer's common stock. F2 · balance_after: Represents 2,270 restricted stock units. Read SEC document |
| August 07, 2018 Filed Aug 9, 2018 20:11 UTC |
Connolly John MDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,900 | $0.00 Strike: $14.80 | $0.00 |
DisclosureSEC source: 0000899243-18-021992 · doc4.xml · derivative · entry 2 Connolly John M · CIK 0001482893 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,900 Underlying: Common Stock · 7,900 shares Expires 2028-08-07 Read SEC document |
| August 07, 2018 Filed Aug 9, 2018 20:11 UTC |
Connolly John MDirector
|
GrantCommon Stock | 2,270 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-021992 · doc4.xml · nonDerivative · entry 1 Connolly John M · CIK 0001482893 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,270 F1 · shares: Represents restricted stock units that vest as to 100% of the shares on December 31, 2018. Each restricted stock unit represents the right to receive one share of the Issuer's common stock. F2 · balance_after: Represents 2,270 restricted stock units. Read SEC document |
| August 07, 2018 Filed Aug 10, 2018 00:12 UTC |
Madaus Martin DDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,900 | $0.00 Strike: $14.80 | $0.00 |
DisclosureSEC source: 0001104659-18-051032 · a4.xml · derivative · entry 3 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,900 Underlying: Common Stock · 7,900 shares Expires 2028-08-07 Read SEC document |
| August 07, 2018 Filed Aug 10, 2018 00:12 UTC |
Madaus Martin DDirector
|
GrantCommon Stock | 2,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-051032 · a4.xml · nonDerivative · entry 1 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,270 F1 · shares: Represents restricted stock units that vest as to 100% of the shares on December 31, 2018. Each restricted stock unit represents the right to receive one share of the Issuer's common stock. F2 · balance_after: Represents 2,270 restricted stock units. Read SEC document |
| August 07, 2018 Filed Aug 9, 2018 20:12 UTC |
WALT DAVID RDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,900 | $0.00 Strike: $14.80 | $0.00 |
DisclosureSEC source: 0001104659-18-051030 · a4.xml · derivative · entry 2 WALT DAVID R · CIK 0001205236 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,900 Underlying: Common Stock · 7,900 shares Expires 2028-08-07 Read SEC document |
| August 07, 2018 Filed Aug 9, 2018 20:12 UTC |
WALT DAVID RDirector
|
GrantCommon Stock | 2,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-051030 · a4.xml · nonDerivative · entry 1 WALT DAVID R · CIK 0001205236 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,217,770 F1 · shares: Represents restricted stock units that vest as to 100% of the shares on December 31, 2018. Each restricted stock unit represents the right to receive one share of the Issuer's common stock. F2 · balance_after: Represents 1,215,500 shares of common stock and 2,270 restricted stock units. Read SEC document |
| August 07, 2018 Filed Aug 9, 2018 20:12 UTC |
DEKKERS MARIJN EDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,900 | $0.00 Strike: $14.80 | $0.00 |
DisclosureSEC source: 0001104659-18-051028 · a4.xml · derivative · entry 2 DEKKERS MARIJN E · CIK 0001216068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,900 Underlying: Common Stock · 7,900 shares Expires 2028-08-07 Read SEC document |
| August 07, 2018 Filed Aug 9, 2018 20:12 UTC |
DEKKERS MARIJN EDirector
|
GrantCommon Stock | 2,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-051028 · a4.xml · nonDerivative · entry 1 DEKKERS MARIJN E · CIK 0001216068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,648 F1 · shares: Represents restricted stock units that vest as to 100% of the shares on December 31, 2018. Each restricted stock unit represents the right to receive one share of the Issuer's common stock. F2 · balance_after: Represents 117,378 shares of common stock and 2,270 restricted stock units. Read SEC document |
| August 07, 2018 Filed Aug 10, 2018 00:12 UTC |
CRANDELL KEITHDirector · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 7,900 | $0.00 Strike: $14.80 | $0.00 |
DisclosureSEC source: 0001104659-18-051027 · a4.xml · derivative · entry 4 CRANDELL KEITH · CIK 0001219039 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,900 Underlying: Common Stock · 7,900 shares Expires 2028-08-07 Read SEC document |
| August 07, 2018 Filed Aug 10, 2018 00:12 UTC |
CRANDELL KEITHDirector · 10% owner
|
GrantCommon Stock | 2,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-051027 · a4.xml · nonDerivative · entry 1 CRANDELL KEITH · CIK 0001219039 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,270 F1 · shares: Represents restricted stock units that vest as to 100% of the shares on December 31, 2018. Each restricted stock unit represents the right to receive one share of the Issuer's common stock. F2 · balance_after: Represents 2,270 restricted stock units. Read SEC document |
| August 07, 2018 Filed Aug 9, 2018 20:12 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
GrantCommon Stock | 300,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-051033 · a4.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,193,972 F1 · shares: Represents restricted stock units that vest as to 50,000 shares on August 31, 2018 and as to the remainder of the shares in 40 equal monthly installments at the end of each successive month. Each restricted stock unit represents the right to receive one share of the Issuer's common stock. F2 · balance_after: Includes 11,470 shares of common stock that are subject to time based vesting, 39,815 shares of common stock that are subject to performance based vesting and 300,000 restricted stock units. Read SEC document |
| June 05, 2018 Filed Jun 5, 2018 16:15 UTC |
Orticerio ErnestSVP Finance and Corporate Dev
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $2.28 | $0.00 |
DisclosureSEC source: 0001562180-18-002871 · primarydocument.xml · derivative · entry 3 Orticerio Ernest · CIK 0001724369 · SVP Finance and Corporate Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,670 Underlying: Common Stock · 25,000 shares Expires 2022-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Vests 23,335 share(s) on 02-Jan-2013, 1,944 share(s) on 31-Jan-2013, 1,944 share(s) on 28-Feb-2013, 1,944 share(s) on 31-Mar-2013, 1,944 share(s) on 30-Apr-2013, 1,944 share(s) on 31-May-2013, 1,944 share(s) on 30-Jun-2013, 1,944 share(s) on 31-Jul-2013, 1,944 share(s) on 31-Aug-2013, 1,944 share(s) on 30-Sep-2013, 1,944 share(s) on 31-Oct-2013, 1,046 share(s) on 30-Nov-2013, 1,944 share(s) on 31-Jan-2014, 1,944 share(s) on 28-Feb-2014, 1,944 share(s) on 31-Mar-2014, 1,944 share(s) on 30-Apr-2014, 1,944 share(s) on 31-May-2014, 1,944 share(s) on 30-Jun-2014, 1,944 share(s) on 31-Jul-2014, 1,944 share(s) on 31-Aug-2014, 1,944 share(s) on 30-Sep-2014, 1,944 share(s) on 31-Oct-2014, 1,944 share(s) on 30-Nov-2014, 1,944 share(s) on 31-Dec-2014, 1,944 share(s) on 31-Jan-2015, 1,944 share(s) on 28-Feb-2015, 1,944 share(s) on 31-Mar-2015, 1,944 share(s) on 30-Apr-2015, 1,944 share(s) on 31-May-2015, 1,944 share(s) on 30-Jun-2015, 1,944 share(s) on 31-Jul-2015, 1,944 share(s) on 31-Aug-2015, 1 Read SEC document |
| June 05, 2018 Filed Jun 5, 2018 16:15 UTC |
Orticerio ErnestSVP Finance and Corporate Dev
|
SaleCommon Stock | 25,000 | $17.15 | $428,632.50 |
DisclosureSEC source: 0001562180-18-002871 · primarydocument.xml · nonDerivative · entry 2 Orticerio Ernest · CIK 0001724369 · SVP Finance and Corporate Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,802 F1 · balance_after: Includes 7,131 restricted stock units that vest as to 25% of the shares on May 10, 2019 and as to an additional 2.083% of the shares per month for 36 months thereafter. Read SEC document |
| June 05, 2018 Filed Jun 5, 2018 16:15 UTC |
Orticerio ErnestSVP Finance and Corporate Dev
|
Exercise / conversionCommon Stock | 25,000 | $2.28 | $57,000.00 |
DisclosureSEC source: 0001562180-18-002871 · primarydocument.xml · nonDerivative · entry 1 Orticerio Ernest · CIK 0001724369 · SVP Finance and Corporate Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,802 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 7,131 restricted stock units that vest as to 25% of the shares on May 10, 2019 and as to an additional 2.083% of the shares per month for 36 months thereafter. Read SEC document |
| May 10, 2018 Filed May 14, 2018 21:00 UTC |
Orticerio ErnestSVP Finance and Corporate Dev
|
GrantStock Option (right to buy) · Derivative | 24,311 | $0.00 Strike: $19.12 | $0.00 |
DisclosureSEC source: 0001104659-18-033074 · a4.xml · derivative · entry 2 Orticerio Ernest · CIK 0001724369 · SVP Finance and Corporate Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,311 Underlying: Common Stock · 24,311 shares Expires 2028-05-10 F3 · derivative.exercise_date: The option vests as to 25% of the shares on May 10, 2019 and vests as to an additional 2.083% of the shares per month for 36 months thereafter. Read SEC document |
| May 10, 2018 Filed May 14, 2018 21:00 UTC |
Orticerio ErnestSVP Finance and Corporate Dev
|
GrantCommon Stock | 7,131 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-033074 · a4.xml · nonDerivative · entry 1 Orticerio Ernest · CIK 0001724369 · SVP Finance and Corporate Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,802 F1 · shares: Represents shares of common stock issuable upon vesting of restricted stock units. The restricted stock units vest as to 25% of the shares on May 10, 2019 and vest as to an additional 2.083% of the shares per month for 36 months thereafter. F2 · balance_after: Represents 46,671 shares of common stock and 7,131 restricted stock units. Read SEC document |
| May 10, 2018 Filed May 14, 2018 21:00 UTC |
BAL BRUCE JVP of Ops, Service and Quality
|
GrantStock Option (right to buy) · Derivative | 18,700 | $0.00 Strike: $19.12 | $0.00 |
DisclosureSEC source: 0001104659-18-033076 · a4.xml · derivative · entry 2 BAL BRUCE J · CIK 0001263377 · VP of Ops, Service and Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,700 Underlying: Common Stock · 18,700 shares Expires 2028-05-10 F3 · derivative.exercise_date: The option vests as to 25% of the shares on May 10, 2019 and vests as to an additional 2.083% of the shares per month for 36 months thereafter. Read SEC document |
| May 10, 2018 Filed May 14, 2018 21:00 UTC |
BAL BRUCE JVP of Ops, Service and Quality
|
GrantCommon Stock | 5,485 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-033076 · a4.xml · nonDerivative · entry 1 BAL BRUCE J · CIK 0001263377 · VP of Ops, Service and Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,485 F1 · shares: Represents shares of common stock issuable upon vesting of restricted stock units. The restricted stock units vest as to 25% of the shares on May 10, 2019 and vest as to an additional 2.083% of the shares per month for 36 months thereafter. F2 · balance_after: Represents 5,485 restricted stock units. Read SEC document |
| May 10, 2018 Filed May 14, 2018 21:00 UTC |
DRISCOLL JOSEPHChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 14,960 | $0.00 Strike: $19.12 | $0.00 |
DisclosureSEC source: 0001104659-18-033073 · a4.xml · derivative · entry 2 DRISCOLL JOSEPH · CIK 0001392297 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,960 Underlying: Common Stock · 14,960 shares Expires 2028-05-10 F3 · derivative.exercise_date: The option vests as to 25% of the shares on May 10, 2019 and vests as to an additional 2.083% of the shares per month for 36 months thereafter. Read SEC document |
| May 10, 2018 Filed May 14, 2018 21:00 UTC |
DRISCOLL JOSEPHChief Financial Officer
|
GrantCommon Stock | 4,388 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-033073 · a4.xml · nonDerivative · entry 1 DRISCOLL JOSEPH · CIK 0001392297 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,388 F1 · shares: Represents shares of common stock issuable upon vesting of restricted stock units. The restricted stock units vest as to 25% of the shares on May 10, 2019 and vest as to an additional 2.083% of the shares per month for 36 months thereafter. F2 · balance_after: Represents 4,388 restricted stock units. Read SEC document |
| May 10, 2018 Filed May 15, 2018 01:01 UTC |
Mattoon DawnSr VP, Stgc Mrktg & Assay Tech
|
GrantStock Option (right to buy) · Derivative | 26,181 | $0.00 Strike: $19.12 | $0.00 |
DisclosureSEC source: 0001104659-18-033078 · a4.xml · derivative · entry 2 Mattoon Dawn · CIK 0001731785 · Sr VP, Stgc Mrktg & Assay Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,181 Underlying: Common Stock · 26,181 shares Expires 2028-05-10 F3 · derivative.exercise_date: The option vests as to 25% of the shares on May 10, 2019 and vests as to an additional 2.083% of the shares per month for 36 months thereafter. Read SEC document |
| May 10, 2018 Filed May 15, 2018 01:01 UTC |
Mattoon DawnSr VP, Stgc Mrktg & Assay Tech
|
GrantCommon Stock | 7,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-033078 · a4.xml · nonDerivative · entry 1 Mattoon Dawn · CIK 0001731785 · Sr VP, Stgc Mrktg & Assay Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,680 F1 · shares: Represents shares of common stock issuable upon vesting of restricted stock units. The restricted stock units vest as to 25% of the shares on May 10, 2019 and vest as to an additional 2.083% of the shares per month for 36 months thereafter. F2 · balance_after: Represents 7,680 restricted stock units. Read SEC document |
| May 10, 2018 Filed May 15, 2018 01:00 UTC |
Duffy David C.SVP R&D and CTO
|
GrantStock Option (right to buy) · Derivative | 18,700 | $0.00 Strike: $19.12 | $0.00 |
DisclosureSEC source: 0001104659-18-033077 · a4.xml · derivative · entry 2 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,700 Underlying: Common Stock · 18,700 shares Expires 2028-05-10 F3 · derivative.exercise_date: The option vests as to 25% of the shares on May 10, 2019 and vests as to an additional 2.083% of the shares per month for 36 months thereafter. Read SEC document |
| May 10, 2018 Filed May 15, 2018 01:00 UTC |
Duffy David C.SVP R&D and CTO
|
GrantCommon Stock | 5,485 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-033077 · a4.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,598 F1 · shares: Represents shares of common stock issuable upon vesting of restricted stock units. The restricted stock units vest as to 25% of the shares on May 10, 2019 and vest as to an additional 2.083% of the shares per month for 36 months thereafter F2 · balance_after: Represents 31,113 shares of common stock and 5,485 restricted stock units. Read SEC document |
| May 10, 2018 Filed May 15, 2018 01:00 UTC |
Roskey Mark T.SVP and GM Apps and Reagents
|
GrantStock Option (right to buy) · Derivative | 24,311 | $0.00 Strike: $19.12 | $0.00 |
DisclosureSEC source: 0001104659-18-033075 · a4.xml · derivative · entry 2 Roskey Mark T. · CIK 0001724565 · SVP and GM Apps and Reagents 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,311 Underlying: Common Stock · 24,311 shares Expires 2028-05-10 F3 · derivative.exercise_date: The option vests as to 25% of the shares on May 10, 2019 and vests as to an additional 2.083% of the shares per month for 36 months thereafter. Read SEC document |
| May 10, 2018 Filed May 15, 2018 01:00 UTC |
Roskey Mark T.SVP and GM Apps and Reagents
|
GrantCommon Stock | 7,131 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-033075 · a4.xml · nonDerivative · entry 1 Roskey Mark T. · CIK 0001724565 · SVP and GM Apps and Reagents 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,131 F1 · shares: Represents shares of common stock issuable upon vesting of restricted stock units. The restricted stock units vest as to 25% of the shares on May 10, 2019 and vest as to an additional 2.083% of the shares per month for 36 months thereafter. F2 · balance_after: Represents 7,131 restricted stock units. Read SEC document |
| May 10, 2018 Filed Feb 27, 2019 21:05 UTC Amendment |
Mattoon DawnSr VP, Stgc Mrktg & Assay Tech
|
GrantCommon Stock | 7,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-19-001457 · primarydocument.xml · nonDerivative · entry 1 Mattoon Dawn · CIK 0001731785 · Sr VP, Stgc Mrktg & Assay Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,680 F1 · shares: Represents shares of common stock issuable upon vesting of restricted stock units. The restricted stock units vest as to 25% of the shares on May 10, 2019 and vest as to an additional 2.083% of the shares per month for 36 months thereafter. F2 · balance_after: Includes 17,680 shares of restricted stock units Read SEC document |
| February 23, 2018 Filed Feb 27, 2018 18:03 UTC |
Mattoon DawnSr VP, Stgc Mrktg & Assay Tech
|
GrantStock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $22.12 | $0.00 |
DisclosureSEC source: 0001104659-18-012911 · a4.xml · derivative · entry 2 Mattoon Dawn · CIK 0001731785 · Sr VP, Stgc Mrktg & Assay Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2028-02-23 F2 · derivative.exercise_date: The option vests as to 25% of the shares on February 23, 2019 and vests as to an additional 2.083% of the shares per month for 36 months thereafter. Read SEC document |
| February 23, 2018 Filed Feb 27, 2018 18:03 UTC |
Mattoon DawnSr VP, Stgc Mrktg & Assay Tech
|
GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-012911 · a4.xml · nonDerivative · entry 1 Mattoon Dawn · CIK 0001731785 · Sr VP, Stgc Mrktg & Assay Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 F1 · shares: Represents shares of common stock issuable upon vesting of restricted stock units. The restricted stock units vest as to 25% of the shares on February 23, 2019 and vest as to an additional 2.083% of the shares per month for 36 months thereafter. Read SEC document |
| December 13, 2017 Filed Dec 18, 2017 16:14 UTC |
Orticerio ErnestSVP Finance and Corporate Dev
|
Exercise / conversionStock Option (right to buy) · Derivative | 46,671 | $0.00 Strike: $2.28 | $0.00 |
DisclosureSEC source: 0001104659-17-073868 · a4.xml · derivative · entry 2 Orticerio Ernest · CIK 0001724369 · SVP Finance and Corporate Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,670 Underlying: Common Stock · 46,671 shares Expires 2022-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: All shares underlying this option have vested. Read SEC document |
| December 13, 2017 Filed Dec 18, 2017 16:14 UTC |
Orticerio ErnestSVP Finance and Corporate Dev
|
Exercise / conversionCommon Stock | 46,671 | $2.28 | $106,409.88 |
DisclosureSEC source: 0001104659-17-073868 · a4.xml · nonDerivative · entry 1 Orticerio Ernest · CIK 0001724369 · SVP Finance and Corporate Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,671 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 11, 2017 Filed Dec 11, 2017 17:27 UTC |
BAIN CAPITAL VENTURE INVESTORS, LLC10% owner
BAIN CAPITAL VENTURE FUND 2005, L.P.10% owner
BCIP Associates III, LLC10% owner
BCIP Associates III10% owner
BCIP Associates III-B, LLC10% owner
BCIP Associates III-B10% owner
KRUPKA MICHAEL A10% owner
Agarwal Ajay10% owner
|
ConversionSeries D Preferred Stock · Derivative | 404,632 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-17-028491 · doc4.xml · derivative · entry 10 BAIN CAPITAL VENTURE INVESTORS, LLC · CIK 0001309469 · 10% owner BAIN CAPITAL VENTURE PARTNERS 2005, L.P. · CIK 0001309470 · 10% owner BAIN CAPITAL VENTURE FUND 2005, L.P. · CIK 0001309471 · 10% owner BCIP Associates III, LLC · CIK 0001379475 · 10% owner BCIP Associates III · CIK 0001379476 · 10% owner BCIP Associates III-B, LLC · CIK 0001379517 · 10% owner BCIP Associates III-B · CIK 0001379519 · 10% owner KRUPKA MICHAEL A · CIK 0001212150 · 10% owner Agarwal Ajay · CIK 0001708763 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 Underlying: Common Stock · 125,900 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The shares of preferred stock automatically converted into common stock immediately prior to the closing of the Issuer's initial public offering using a calculation defined in the Issuer's Restated Certificate of Incorporation, as amended, based on the initial purchase price and the conversion rate in effect at the time of conversion. The shares of preferred stock automatically converted on a 1-for-3.214 basis and such conversion rate is reflected in the amount of common stock underlying the security. F1 · price: The shares of preferred stock automatically converted into common stock immediately prior to the closing of the Issuer's initial public offering using a calculation defined in the Issuer's Restated Certificate of Incorporation, as amended, based on the initial purchase price and the conversion rate in effect at the time of conversion. The shares of preferred stock automatically converted on a 1-for-3.214 basis and such conversion rate is reflected in the amount of common stock underlying the security. F6 · derivative.exercise_date: These shares were convertible into the Issuer's common stock in accordance with the Issuer's Restated Certificate of Incorporation, as amended, at any time after the issuance of such shares, at the holder's election. F7 · derivative.expiration_date: Not applicable. F2 · ownership.nature: Bain Capital Venture Investors, LLC ("BCVI") is the general partner of Bain Capital Venture Partners 2005, L.P. ("BCVP"), which is the general partner of Bain Capital Venture Fund 2005, L.P. ("Fund 2005"). As a result, BCVP may be deemed to share voting and dispositive power with respect to the securities held by Fund 2005. BCVP disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Immediately prior to the closing of the Issuer's initial public offering on December 11, 2017, the 1,106,387 shares of the Issuer's Series A-1 Preferred Stock, 2,904,268 shares of the Issuer's Series A-2 Preferred Stock, 1,325,258 shares of the Issuer's Series B Preferred Stock, 304,948 shares of the Issuer's Series C Preferred Stock and 353,283 shares of the Issuer's Series D Preferred Stock held by Fund 2005 automatically converted into 344,239, 903,630, 412,339, 94,881 and 109,921 shares of the Issuer's common stock, respectively. F3 · ownership.nature: Immediately prior to the closing of the Issuer's initial public offering on December 11, 2017, the 157,639 shares of the Issuer's Series A-1 Preferred Stock, 413,802 shares of the Issuer's Series A-2 Preferred Stock, 188,823 shares of the Issuer's Series B Preferred Stock, 43,449 shares of the Issuer's Series C Preferred Stock and 50,336 shares of the Issuer's Series D Preferred Stock held by BCIP Associates III, LLC ("BCIP III"), whose manager is BCIP Associates III ("BCIPA III"), whose managing partner is Boylston Coinvestors, LLC ("Boylston"), automatically converted into 49,047, 128,749, 58,750, 13,518 and 15,663 shares of the Issuer's common stock, respectively. BCIPA III may be deemed to share voting and dispositive power with respect to the securities held by BCIP III. BCIPA III disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. F4 · ownership.nature: Immediately prior to the closing of the Issuer's initial public offering on December 11, 2017, the 3,174 shares of the Issuer's Series A-1 Preferred Stock, 8,331 shares of the Issuer's Series A-2 Preferred Stock, 3,799 shares of the Issuer's Series B Preferred Stock, 874 shares of the Issuer's Series C Preferred Stock and 1,013 shares of the Issuer's Series D Preferred Stock held by BCIP Associates III-B, LLC ("BCIP III-B" and together with Fund 2005 and BCIP III, the "Bain Capital Entities"), whose manager is BCIP Associates III-B ("BCIPA III-B"), whose managing partner is Boylston, automatically converted into 987, 2,592, 1,182, 271 and 316 shares of the Issuer's common stock, respectively. BCIPA III-B may be deemed to share voting and dispositive power with respect to the securities held by BCIP III-B. BCIPA III-B disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. F5 · ownership.nature: The governance, investment strategy and decision-making process with respect to the investments held by the Bain Capital Entities is directed by the Executive Committee of BCVI, which consists of Michael A. Krupka and Ajay Agarwal. As a result, BCVI and Messrs. Krupka and Agarwal may be deemed to share voting and dispositive power with respect to the securities held by the Bain Capital Entities. BCVI and Messrs. Krupka and Agarwal disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.